The simple is fast
SWIPP develops medical oral films for faster absorption and easier administration
Welcome to SWIPP
For us, time and what’s patient-friendly matter, in many ways: How easy is it to use the product, for patients, relatives and healthcare professionals? How quickly is the drug molecule absorbed into the body? And, how quickly is the product available when you really need it?
Time to market is also important for us. That is, how quickly can we develop a new medicine. That’s why we work on projects based on safe and well-established pharmaceutical substances, that will only need very limited clinical programmes.
Our aim is that it should take no more than 3 years from idea to first clinical trial.
Our first project is in epilepsy, where we are developing an easy-to-use buccal film with midazolam for the treatment of acute, ongoing epileptic seizures. It has already been tested in two clinical trials. This is a perfect example of the need for patient-friendly and easy-to-use medicines for vulnerable patient groups. Those are the needs we want to meet.
EPILEPTIC SEIZURES CAN RAPIDLY BECOME SERIOUS
That’s why the solution must be simple and fast